Enhanced-autophagy by exenatide mitigates doxorubicin-induced cardiotoxicity.
Sign Up to like & getrecommendations! Published in 2017 at "International journal of cardiology"
DOI: 10.1016/j.ijcard.2017.01.123
Abstract: OBJECTIVES Exenatide is a glucagon-like peptide-1 analogue that mitigates myocardial injury caused by ischemia-reperfusion injury via the survival signaling pathway. We hypothesized that exenatide would provide a protective effect in doxorubicin-induced cardiotoxicity. METHODS H9c2 cardiomyocytes… read more here.
Keywords: dox induced; doxorubicin induced; induced cardiotoxicity; treatment ... See more keywords
Changes in glycemic variability, gastric emptying and vascular endothelial function after switching from twice-daily to once-weekly exenatide in patients with type 2 diabetes: a subpopulation analysis of the twin-exenatide study
Sign Up to like & getrecommendations! Published in 2022 at "BMC Endocrine Disorders"
DOI: 10.1186/s12902-022-00932-9
Abstract: Background We investigated the changes in blood glucose fluctuation, gastric emptying, and vascular endothelial function by switching from an exenatide twice-daily formulation (BID) to a once-weekly formulation (QW) since the evaluation of postprandial glucose excursion… read more here.
Keywords: gastric emptying; endothelial function; vascular endothelial; exenatide ... See more keywords